Trenova AG, Slavov GS, Manova MG, Aksentieva JB, Miteva LD, Stanilova SA. Cognitive impairment in multiple sclerosis. Folia Med (Plovdiv). 2016;58(3):157–63.
Article
Google Scholar
Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, et al. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis. Mult Scler. 2013;19(10):1290–6.
Article
Google Scholar
Geurts JJ, Calabrese M, Fisher E, Rudick RA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 2012;11(12):1082–92.
Article
Google Scholar
Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010;75(22):1988–94.
Article
CAS
Google Scholar
Fischer MT, Wimmer I, Höftberger R, Gerlach S, Haider L, Zrzavy T, et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain. 2013;136(6):1799–815.
Article
Google Scholar
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.
Article
Google Scholar
Rimkus CM, Schoonheim MM, Steenwijk MD, Vrenken H, Eijlers AJ, Killestein J, et al. Gray matter networks and cognitive impairment in multiple sclerosis. Mult Scler. 2019;25(3):382–91.
Article
Google Scholar
Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain. 2012;135(10):2952–61.
Article
Google Scholar
Miller E, Morel A, Redlicka J, Miller I, Saluk J. Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis. Curr Neuropharmacol. 2018;16(4):475–83.
Article
CAS
Google Scholar
Charvet LE, Taub E, Cersosimo B, Rosicki C, Melville P, Krupp LB. The Montreal cognitive assessment (MoCA) in multiple sclerosis: relation to clinical features. J Mult Scler. 2015;2(135):2376–0389.
Google Scholar
Parmenter BA, Weinstock-Guttman B, Garg N, Munschauer F, Benedict RH. Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test. Mult Scler. 2007;13(1):52–7.
Article
CAS
Google Scholar
Elkholy SF, Sabet MA, Mohammad ME, Asaad RE. Comparative study between double inversion recovery (DIR) and fluid-attenuated inversion recovery (FLAIR) MRI sequences for detection of cerebral lesions in multiple sclerosis. Egypt J Radiol Nuclear Med. 2020;51(1):1–0.
Article
Google Scholar
Favaretto A, Poggiali D, Lazzarotto A, Rolma G, Causin F, Gallo P. The parallel analysis of phase sensitive inversion recovery (PSIR) and double inversion recovery (DIR) images significantly improves the detection of cortical lesions in multiple sclerosis (MS) since clinical onset. Plos One. 2015;10(5):e0127805.
Article
Google Scholar
Simon B, Schmidt S, Lukas C, Gieseke J, Träber F, Knol DL, et al. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol. 2010;20(7):1675–83.
Article
Google Scholar
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52.
Article
CAS
Google Scholar
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.
Article
Google Scholar
Milani SA, Marsiske M, Cottler LB, Chen X, Striley CW. Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity. Alzheimers Dement (Amst). 2018;10:773–81.
Article
Google Scholar
Smith A. The symbol-digit modalities test: a neuropsychologic test of learning and other cerebral disorders. Learn Disord. 1968;3:83–91.
Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology. 2011;76(5):418–24.
Article
CAS
Google Scholar
Sethi V, Muhlert N, Ron M, Golay X, Wheeler-Kingshott CA, Miller DH, et al. MS cortical lesions on DIR: not quite what they seem? Plos One. 2013;8(11):e78879.
Article
CAS
Google Scholar
Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016;15(3):292–303.
Article
Google Scholar
Parodi RC, Sardanelli F, Renzetti P, Rosso E, Losacco C, Ferrari A, et al. Growing region segmentation software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra-and inter-observer agreement variability: a comparison with manual contouring method. Eur Radiol. 2002;12(4):866–71.
Article
Google Scholar
Elnekeidy AM, Kamal MA, Elfatatry AM, Elskeikh ML. Added value of double inversion recovery magnetic resonance sequence in detection of cortical and white matter brain lesions in multiple sclerosis. Egypt J Radiol Nuclear Med. 2014;45(4):1193–9.
Article
Google Scholar
Abidi Z, Faeghi F, Mardanshahi Z, Mortazavi H. Assessment of the diagnostic accuracy of double inversion recovery sequence compared with FLAIR and T2W_TSE in detection of cerebral multiple sclerosis lesions. Electron Physician. 2017;9(4):4162–70.
Article
Google Scholar
Matsushita F, Kida H, Tabei KI, Nakano C, Matsuura K, Ii Y, et al. Clinical significance of cortical lesions in patients with multiple sclerosis: a neuropsychological and neuroimaging study. Brain Behav. 2018;8(3):e00934.
Article
Google Scholar
Nelson F, Datta S, Garcia N, Rozario NL, Perez F, Cutter G, et al. Intracortical lesions by 3 T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult Scler. 2011;17(9):1122–9.
Article
Google Scholar
Harrison DM, Roy S, Oh J, Izbudak I, Pham D, Courtney S, et al. Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol. 2015;72(9):1004–12.
Article
Google Scholar
Deloire MS, Ruet A, Hamel D, Bonnet M, Dousset V, Brochet B. MRI predictors of cognitive outcome in early multiple sclerosis. Neurology. 2011;76(13):1161–7.
Article
CAS
Google Scholar
Rossi F, Giorgio A, Battaglini M, Stromillo ML, Portaccio E, Goretti B, et al. Relevance of brain lesion location to cognition in relapsing multiple sclerosis. Plos one. 2012;7(11):e44826.
Article
CAS
Google Scholar
Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D, et al. Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. Plos One. 2015;10(3):e0120754.
Article
Google Scholar
Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RH, et al. Brain MRI lesion load at 1.5 T and 3 T versus clinical status in multiple sclerosis. J Neuroimaging. 2011;21(2):e50–6.
Article
Google Scholar
Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, et al. Cognition in multiple sclerosis: state of the field and priorities for the future. Neurology. 2018;90(6):278–88.
Article
Google Scholar